This was the stock's 11th consecutive day of gains.

With an average analyst rating of buy, Humana is clearly an analyst favorite. But the analysts could be wrong. Is HUM overvalued at today's price of $243.33? Let's take a closer look at the ...

Humana (NYSE:HUM) has recently introduced Humana Healthy Horizons, a new Medicaid plan for Virginians under Cardinal Care, highlighting its focus on expanding in the Medicaid sector. This move ...